Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council
- DOI
- 10.1016/j.jdin.2020.09.006
- Published
- 2020-12
- Container
- JAAD International
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jdin.2020.09.006,
title = {Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council},
author = {Arnon D. Cohen and Ronald Vender and Luigi Naldi and Robert E. Kalb and Tiago Torres and Murlidhar Rajagopalan and Joelle van der Walt and Lluís Puig and Helen S. Young},
year = {2020},
journal = {JAAD International},
doi = {10.1016/j.jdin.2020.09.006},
url = {https://doi.org/10.1016/j.jdin.2020.09.006}
}RIS
TY - JOUR TI - Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council AU - Arnon D. Cohen AU - Ronald Vender AU - Luigi Naldi AU - Robert E. Kalb AU - Tiago Torres AU - Murlidhar Rajagopalan AU - Joelle van der Walt AU - Lluís Puig AU - Helen S. Young PY - 2020 JO - JAAD International DO - 10.1016/j.jdin.2020.09.006 UR - https://doi.org/10.1016/j.jdin.2020.09.006 ER -
APA
Cohen, A. D., Vender, R., Naldi, L., Kalb, R. E., Torres, T., Rajagopalan, M., Walt, J. V. D., Puig, L., & Young, H. S. (2020). Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council. JAAD International. https://doi.org/10.1016/j.jdin.2020.09.006
Source records
- crossref · retrieved 2026-09-26T14:53:54.044Z